大禹生物
(871970)
| 流通市值：3.54亿 | | | 总市值：7.47亿 |
| 流通股本：5270.44万 | | | 总股本：1.11亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 24,108,136.44 | 21,339,825.48 | 34,428,100.42 | 45,112,911.72 |
| 应收票据及应收账款 | 25,711,456.69 | 18,202,220.52 | 18,550,106.46 | 21,501,640.1 |
| 其中：应收票据 | 100,000 | 100,000 | 500,000 | 600,000 |
| 应收账款 | 25,611,456.69 | 18,102,220.52 | 18,050,106.46 | 20,901,640.1 |
| 预付款项 | 2,506,393.79 | 3,418,828.8 | 3,730,974.59 | 1,956,092.05 |
| 其他应收款合计 | 16,496.43 | 69,480.55 | 104,928.96 | 92,483.96 |
| 存货 | 32,064,700.84 | 33,515,851.53 | 36,250,668.88 | 33,751,160.28 |
| 其他流动资产 | 1,147,733.81 | 3,174,493.48 | 2,976,003.13 | 2,709,645.22 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 85,554,918 | 79,720,700.36 | 96,040,782.44 | 105,123,933.33 |
| 非流动资产: | | | | |
| 固定资产 | 163,470,218.45 | 167,302,499.75 | 168,780,796.16 | 167,657,563.77 |
| 在建工程 | 137,542,382.36 | 130,651,181.81 | 104,740,406.44 | 90,767,241.17 |
| 无形资产 | 24,614,789.88 | 24,845,358.9 | 25,075,927.92 | 25,306,496.94 |
| 长期待摊费用 | 39,930.85 | 65,630.26 | 102,880.66 | 140,131.24 |
| 递延所得税资产 | 583,055.06 | 570,542 | 515,556.58 | 552,133.11 |
| 其他非流动资产 | 18,396,582.65 | 21,663,182.65 | 38,698,006.65 | 43,769,687.49 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 344,646,959.25 | 345,098,395.37 | 337,913,574.41 | 328,193,253.72 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 430,201,877.25 | 424,819,095.73 | 433,954,356.85 | 433,317,187.05 |
| 流动负债: | | | | |
| 短期借款 | 70,000,000 | 60,000,000 | 31,000,000 | 17,006,572.23 |
| 应付票据及应付账款 | 9,319,279.57 | 7,147,065.11 | 6,126,780.74 | 9,657,591.63 |
| 应付账款 | 9,319,279.57 | 7,147,065.11 | 6,126,780.74 | 9,657,591.63 |
| 合同负债 | 2,633,887.61 | 7,328,040.17 | 3,111,492.57 | 468,995.52 |
| 应付职工薪酬 | 7,534,890.79 | 8,539,834.61 | 9,678,630.44 | 11,179,493.1 |
| 应交税费 | 96,277.93 | 108,374.05 | 42,002.53 | 6,616,218.1 |
| 其他应付款合计 | 395,693.7 | 393,175.5 | 110.22 | 530,593.34 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 89,980,029.6 | 83,516,489.44 | 49,959,016.5 | 45,459,463.92 |
| 非流动负债: | | | | |
| 递延收益 | 27,117,915.73 | 27,971,665.75 | 28,825,415.77 | 29,679,165.79 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 27,117,915.73 | 27,971,665.75 | 28,825,415.77 | 29,679,165.79 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 117,097,945.33 | 111,488,155.19 | 78,784,432.27 | 75,138,629.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 111,360,400 | 111,360,400 | 55,960,000 | 55,960,000 |
| 资本公积 | 85,593,738.02 | 85,593,738.02 | 140,994,138.02 | 140,994,138.02 |
| 减:库存股 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 |
| 盈余公积 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 |
| 未分配利润 | 104,406,463.03 | 104,633,471.65 | 146,472,455.69 | 149,481,088.45 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 313,103,931.92 | 313,330,940.54 | 355,169,924.58 | 358,178,557.34 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 313,103,931.92 | 313,330,940.54 | 355,169,924.58 | 358,178,557.34 |
| 负债和股东权益合计 | 430,201,877.25 | 424,819,095.73 | 433,954,356.85 | 433,317,187.05 |
| 公告日期 | 2023-10-26 | 2023-08-28 | 2023-04-26 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |